A

Allovir (ALVR)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Allovir (ALVR)

AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T-cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to r... Read more

  • 7.25
  • 7.31
  • 6.80
  • 20.63
  • -9.5%
  • --
  • 167.39k
  • 236.92k
  • 724M
  • 3.17
  • -63.9%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.